Quick Answer
BALCHEM CORP reported Stockholders Equity of $1.26 billion for the year ending 2025.
- BALCHEM CORP showed an increase of +9.3% in Stockholders Equity from 2024 to 2025.
- This data is from BALCHEM CORP's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $344.20 million | Q2 2014: $356.22 million | Q3 2014: $376.64 million | Q1 2015: $411.22 million | Q2 2015: $438.22 million | Q3 2015: $457.32 million | Q1 2016: $480.25 million | Q2 2016: $496.15 million | Q3 2016: $516.42 million | Q1 2017: $542.30 million | Q2 2017: $562.38 million | Q3 2017: $585.94 million | Q1 2018: $639.89 million | Q2 2018: $663.22 million | Q3 2018: $685.20 million | Q1 2019: $710.51 million | Q2 2019: $732.35 million | Q3 2019: $733.59 million | Q1 2020: $766.27 million | Q2 2020: $792.52 million | Q3 2020: $819.44 million | Q1 2021: $849.49 million | Q2 2021: $869.64 million | Q3 2021: $889.08 million | Q1 2022: $873.68 million | Q2 2022: $901.37 million | Q3 2022: $895.92 million | Q1 2023: $973.42 million | Q2 2023: $1.01 billion | Q3 2023: $1.03 billion | Q1 2024: $1.08 billion | Q2 2024: $1.11 billion | Q3 2024: $1.18 billion | Q1 2025: $1.21 billion | Q2 2025: $1.27 billion | Q3 2025: $1.30 billion.
- Over the full 16 years of available data (2010 to 2025), BALCHEM CORP's Stockholders Equity has grown by 570.7%.
- Historical annual values: Fiscal year 2025: $1.26 billion | Fiscal year 2024: $1.15 billion | Fiscal year 2023: $1.05 billion | Fiscal year 2022: $938.28 million | Fiscal year 2021: $877.02 million | Fiscal year 2020: $828.23 million | Fiscal year 2019: $743.67 million | Fiscal year 2018: $691.62 million | Fiscal year 2017: $616.88 million | Fiscal year 2016: $521.03 million | Fiscal year 2015: $463.71 million | Fiscal year 2014: $391.90 million | Fiscal year 2013: $331.36 million | Fiscal year 2012: $273.01 million | Fiscal year 2011: $232.01 million | Fiscal year 2010: $187.47 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: